semaglutide alcohol use disorder study Could GLP-1 medications help transform treatment for addiction? Alcohol affects millions, yet there haven't been any new medications approved to treat it in 20 years. Now, new #CUAnschutz research GLP-1 medications: The next big

The randomised, double-blind, placebo-controlled trial was conducted across 12 countries and enrolled 1206 adults with Type 2 diabetes, a body mass index (BMI) of at least 27, and HbA1c between 7% and 10%

This process may cause an energy deficit in some individuals, which could contribute to feelings of tiredness

J Educ Health Promot

Users in community sources commonly describe it as similar to starting an anti-inflammatory protocol, fading by week 2

Conclusions Our study summarized current clinical studies and found that GLP-1 receptor agonists can effectively improve cognitive function, BMI and blood glucose levels in AD patients